Creatine and Kidney Health: 30 Years of Evidence Reviewed

Across more than three decades of research, creatine monohydrate has not been shown to damage kidney function in healthy adults taking recommended doses. The persistent worry comes from a single, well-understood fact: creatine supplementation raises serum creatinine, a number used on blood tests to estimate kidney function. That rise is a measurement artefact of taking creatine, not a sign of kidney damage. The one genuine exception is people with pre-existing kidney disease, who should seek medical advice first.

The kidney question is the most common safety concern raised about creatine, and it has a clear answer in the published literature. The International Society of Sports Nutrition's position stand — the single most cited safety document on the supplement — concludes that there is no compelling evidence that creatine supplementation harms kidney function in healthy individuals (Kreider et al., JISSN 2017). A later comprehensive review reached the same conclusion across the full range of populations studied (Kreider & Stout, Nutrients 2021).

This article explains where the kidney concern originated, why a raised creatinine reading on a blood test does not mean kidney damage, what 30 years of kidney-function studies actually measured, and the specific situation in which medical advice is genuinely required.

Where the kidney concern comes from

The kidney concern is almost entirely traceable to one biochemical relationship: the substance the body makes from creatine is called creatinine, and creatinine is the same molecule clinicians measure to estimate kidney function. The names are nearly identical, the molecules are directly related, and the result is decades of understandable confusion.

Creatinine is a waste product. The body produces it continuously as creatine and phosphocreatine are used inside muscle, and the kidneys filter it out into urine. Because healthy kidneys clear creatinine at a steady rate, the concentration of creatinine left in the blood — serum creatinine — is used as a routine, inexpensive marker of how well the kidneys are filtering. A high serum creatinine reading, in a person who has not changed anything else, can indicate that the kidneys are filtering less efficiently.

Supplementing with creatine increases the size of the body's creatine pool. A larger creatine pool produces more creatinine through normal daily turnover. More creatinine entering the blood raises the serum creatinine reading — even when the kidneys are filtering perfectly normally. The number on the blood test goes up because there is more creatinine being made, not because the kidneys have started failing to clear it (Kreider et al., JISSN 2017).

Serum creatinine: a marker, not a measure of damage

This distinction is the heart of the entire topic, so it warrants stating precisely. Serum creatinine is an indirect estimate of kidney function, not a direct measure of kidney structure or health. It works as an estimate only when the rate at which creatinine is produced stays constant. Creatine supplementation deliberately changes that production rate, which means a raised creatinine reading in someone taking creatine cannot be interpreted the same way as a raised reading in someone who is not.

For this reason, reviews of the evidence recommend that kidney function in people who supplement with creatine be assessed using markers that do not depend on creatinine production — such as cystatin C, or glomerular filtration rate estimated from cystatin C, alongside urinary albumin measures (Kreider & Stout, Nutrients 2021). When kidney function is assessed this way, the apparent effect of creatine disappears: the filtration itself is normal, and only the creatinine-based estimate was ever shifted.

What 30 years of kidney-function studies show

The relationship between creatine and the kidneys has been studied since the supplement entered mainstream use in the early 1990s. The findings have been consistent across short-term loading studies, multi-year supplementation, athletes under heavy training loads, older adults, and clinical populations.

Selected evidence on creatine and kidney function, by population studied.

The conclusion drawn by the International Society of Sports Nutrition is unambiguous: there is no compelling scientific evidence that short- or long-term creatine supplementation, at recommended doses, has any detrimental effect on kidney function in healthy people (Kreider et al., JISSN 2017). The later review extends this across the lifespan and across the clinical populations studied to date, while noting that data in people who already have significant kidney impairment remain limited (Kreider & Stout, Nutrients 2021).

For the adult restarting creatine in their thirties, forties, or fifties — the position from which much active-longevity supplementation begins — the evidence base is reassuring. Decades of study at standard maintenance doses have not produced a signal of kidney harm in people with healthy kidneys.

The standard dose the evidence is built on

The kidney-safety findings above apply to creatine used at the doses studied in the literature. The standard maintenance dose for creatine monohydrate is approximately 3 to 5 grams per day, a figure that has not changed across the research record (Kreider et al., JISSN 2017). The safety conclusions do not licence unlimited intake; they apply to the recommended range. The mechanism behind that range, and how it compares between gummies and powder, is covered in the guidance on how creatine blood levels build with gummies versus powder.

There is no evidence that exceeding the recommended dose improves outcomes, and the safety literature was not built on supra-physiological intakes. Staying within the established maintenance range is the condition under which the 30-year safety record applies.

The genuine caveat: pre-existing kidney disease

The reassurance above is specific to people with healthy kidneys. It does not automatically transfer to people who already have kidney disease, reduced kidney function, or who are at elevated risk of it.

The evidence in people with significant pre-existing kidney impairment is limited, and the effect of supplementary creatine on kidneys that are already not filtering normally has not been established to the same standard (Kreider & Stout, Nutrients 2021). There is a further practical complication: because creatine raises serum creatinine as a marker artefact, it can interfere with the very blood test used to monitor kidney disease, making a clinician's job harder unless they know the person is supplementing.

In the United Kingdom, creatine is sold as a food supplement and is regulated as a food, not a medicine, under the framework overseen by the Food Standards Agency. Supplements may not make medicinal claims — claims to treat, prevent, or cure disease — which fall under the remit of the Medicines and Healthcare products Regulatory Agency (MHRA). Nothing in this article is a medicinal claim, and creatine is not presented here as a treatment for any kidney condition. For anyone with a diagnosed condition, the regulatory point and the medical point align: the decision should be made with a clinician.

This caveat sits alongside the wider set of people for whom caution applies, set out in the guidance on who should not take creatine gummies.

How this fits the broader safety picture

The kidney question is one of several long-standing concerns about creatine, most of which resolve the same way on close reading of the evidence: a plausible-sounding worry that does not survive contact with the controlled data. The same pattern applies to claims about cramping, dehydration, and digestive upset, which are addressed in the overview of what is real and what is myth among creatine gummy side effects.

What separates the kidney concern from the others is that it has a concrete, measurable basis — the serum creatinine shift is real and reproducible — which is precisely why it persists. The shift is genuine; the interpretation that it signals kidney damage is not. Understanding the difference between a marker moving and an organ being harmed is what allows the evidence to be read correctly.

APMZEE's safety-first position

APMZEE's position on safety is to report what the evidence shows and to state the limits of it plainly. The published literature does not support the claim that creatine harms kidney function in healthy adults, and this article reflects that. Equally, the evidence does not extend to people with pre-existing kidney disease, and this article says so directly rather than glossing over it.

That same principle runs through how APMZEE creatine gummies are made and described. The product is manufactured to BRCGS Global Standard for Food Safety, FSSC 22000, ISO 9001, and ISO/IEC 27001, each independently audited, with finished-product testing and Made-in-UK certification. Certified manufacturing does not change the kidney evidence — that comes from the clinical literature — but it does mean the dose stated on the label is the dose in the product, which is the precondition for any safety data applying to what a person actually takes.

FAQs